These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 15756673)

  • 1. Chlamydia trachomatis infection and persistence of human papillomavirus.
    Silins I; Ryd W; Strand A; Wadell G; Törnberg S; Hansson BG; Wang X; Arnheim L; Dahl V; Bremell D; Persson K; Dillner J; Rylander E
    Int J Cancer; 2005 Aug; 116(1):110-5. PubMed ID: 15756673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chlamydia trachomatis and human papillomavirus infection in Indian women with sexually transmitted diseases and cervical precancerous and cancerous lesions.
    Gopalkrishna V; Aggarwal N; Malhotra VL; Koranne RV; Mohan VP; Mittal A; Das BC
    Clin Microbiol Infect; 2000 Feb; 6(2):88-93. PubMed ID: 11168078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Chlamydia trachomatis DNA in human papillomavirus (HPV) positive women with normal and abnormal cytology.
    Finan RR; Tamim H; Almawi WY
    Arch Gynecol Obstet; 2002 Jul; 266(3):168-71. PubMed ID: 12197559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chlamydia Trachomatis Infection in High-Risk Human Papillomavirus Based on Cervical Cytology Specimen.
    Sangpichai S; Patarapadungkit N; Pientong C; Ekalaksananan T; Chaiwiriyakul S; Thongbor R; Sirivech P; Jangsiriwitayakorn P; Triamwittayanon T
    Asian Pac J Cancer Prev; 2019 Dec; 20(12):3843-3847. PubMed ID: 31870131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines.
    Smith JS; Muñoz N; Herrero R; Eluf-Neto J; Ngelangel C; Franceschi S; Bosch FX; Walboomers JM; Peeling RW
    J Infect Dis; 2002 Feb; 185(3):324-31. PubMed ID: 11807714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of
    Martinelli M; Musumeci R; Rizzo A; Muresu N; Piana A; Sotgiu G; Landoni F; Cocuzza C
    Int J Environ Res Public Health; 2019 Sep; 16(18):. PubMed ID: 31514378
    [No Abstract]   [Full Text] [Related]  

  • 7. Detection of Chlamydia trachomatis DNA in cervical samples with regard to infection by human papillomavirus.
    Lehmann M; Groh A; Rödel J; Nindl I; Straube E
    J Infect; 1999 Jan; 38(1):12-7. PubMed ID: 10090499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chlamydia trachomatis and risk of prevalent and incident cervical premalignancy in a population-based cohort.
    Safaeian M; Quint K; Schiffman M; Rodriguez AC; Wacholder S; Herrero R; Hildesheim A; Viscidi RP; Quint W; Burk RD
    J Natl Cancer Inst; 2010 Dec; 102(23):1794-804. PubMed ID: 21098758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervicovaginal coinfections with human papillomavirus and Chlamydia trachomatis.
    Tamim H; Finan RR; Sharida HE; Rashid M; Almawi WY
    Diagn Microbiol Infect Dis; 2002 Aug; 43(4):277-81. PubMed ID: 12151187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chlamydia trachomatis and risk of cervical intraepithelial neoplasia grade 3 or worse in women with persistent human papillomavirus infection: a cohort study.
    Jensen KE; Thomsen LT; Schmiedel S; Frederiksen K; Norrild B; van den Brule A; Iftner T; Kjær SK
    Sex Transm Infect; 2014 Nov; 90(7):550-5. PubMed ID: 24728044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and determinants of Chlamydia trachomatis infections in women from Bogota, Colombia.
    Molano M; Weiderpass E; Posso H; Morré SA; Ronderos M; Franceschi S; Arslan A; Meijer CJ; Muñoz N; van den Brule AJ;
    Sex Transm Infect; 2003 Dec; 79(6):474-8. PubMed ID: 14663124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and persistence of carcinogenic genital human papillomavirus infections in young women with or without Chlamydia trachomatis co-infection.
    Vriend HJ; Bogaards JA; van Bergen JE; Brink AA; van den Broek IV; Hoebe CJ; King AJ; van der Sande MA; Wolffs PF; de Melker HE;
    Cancer Med; 2015 Oct; 4(10):1589-98. PubMed ID: 26194784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A population-based prospective study of Chlamydia trachomatis infection and cervical carcinoma.
    Wallin KL; Wiklund F; Luostarinen T; Angström T; Anttila T; Bergman F; Hallmans G; Ikäheimo I; Koskela P; Lehtinen M; Stendahl U; Paavonen J; Dillner J
    Int J Cancer; 2002 Oct; 101(4):371-4. PubMed ID: 12209962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Association of human papillomavirus infection with other microbial pathogens in gynecology].
    Zheng MY; Zhao HL; Di JP; Lin G; Lin Y; Lin X; Zheng MQ
    Zhonghua Fu Chan Ke Za Zhi; 2010 Jun; 45(6):424-8. PubMed ID: 21029592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infections of the cervix uteri with human papillomavirus and Chlamydia trachomatis.
    Claas EC; Melchers WJ; Niesters HG; van Muyden R; Stolz E; Quint WG
    J Med Virol; 1992 May; 37(1):54-7. PubMed ID: 1320098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [HPV, Chlamydia trachomatis and genital mycoplasmas infections in women with low-grade squamous intraepithelial lesions (LSIL)].
    Friedek D; Ekiel A; Chełmicki Z; Romanik M
    Ginekol Pol; 2004 Jun; 75(6):457-63. PubMed ID: 15524422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type-specific persistence and associated risk factors of human papillomavirus infections in women living in central Italy.
    Sammarco ML; Del Riccio I; Tamburro M; Grasso GM; Ripabelli G
    Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):222-6. PubMed ID: 23395560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of Chlamydia trachomatis and oncogenic human papillomavirus types in cytologic atypia of the uterine cervix.
    Fehér E; Szalmás A
    Acta Microbiol Immunol Hung; 2006 Dec; 53(4):479-87. PubMed ID: 17278714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening.
    Naucler P; Ryd W; Törnberg S; Strand A; Wadell G; Elfgren K; Rådberg T; Strander B; Forslund O; Hansson BG; Hagmar B; Johansson B; Rylander E; Dillner J
    J Natl Cancer Inst; 2009 Jan; 101(2):88-99. PubMed ID: 19141778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of human papillomavirus and Chlamydia trachomatis infection among women attending cervical cancer screening in the Republic of Korea.
    Oh JK; Franceschi S; Kim BK; Kim JY; Ju YH; Hong EK; Chang YC; Rha SH; Kim HH; Kim JH; Kim CY; Shin HR
    Eur J Cancer Prev; 2009 Feb; 18(1):56-61. PubMed ID: 19077566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.